188 related articles for article (PubMed ID: 25151339)
1. Association of altered CuZn superoxide dismutase and cognitive impairment in schizophrenia patients with tardive dyskinesia.
Wu JQ; Chen DC; Tan YL; Tan S; Wang Z; Yang F; Soares JC; Zhang XY
J Psychiatr Res; 2014 Nov; 58():167-74. PubMed ID: 25151339
[TBL] [Abstract][Full Text] [Related]
2. Cognition impairment in schizophrenia patients with tardive dyskinesia: association with plasma superoxide dismutase activity.
Wu JQ; Chen DC; Tan YL; Tan SP; Wang ZR; Xiu MH; Yang FD; Zhang XY
Schizophr Res; 2014 Jan; 152(1):210-6. PubMed ID: 24325977
[TBL] [Abstract][Full Text] [Related]
3. Mn-superoxide dismutase activity is associated with orofacial involuntary movements in schizophrenia patients with tardive dyskinesia.
Wu JQ; Chen DC; Tan YL; Soares JC; Zhang XY
Hum Psychopharmacol; 2015 Jan; 30(1):57-63. PubMed ID: 25572310
[TBL] [Abstract][Full Text] [Related]
4. Tardive dyskinesia is associated with greater cognitive impairment in schizophrenia.
Wu JQ; Chen DC; Xiu MH; Tan YL; Yang FD; Kosten TR; Zhang XY
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():71-7. PubMed ID: 23827756
[TBL] [Abstract][Full Text] [Related]
5. Clinical symptoms and cognitive impairment associated with male schizophrenia relate to plasma manganese superoxide dismutase activity: a case-control study.
Zhang XY; Chen DC; Xiu MH; Tan YL; Yang FD; Zhang LY; Zhang LY; Haile CN; Kosten TR
J Psychiatr Res; 2013 Aug; 47(8):1049-53. PubMed ID: 23611682
[TBL] [Abstract][Full Text] [Related]
6. Altered BDNF is correlated to cognition impairment in schizophrenia patients with tardive dyskinesia.
Wu JQ; Chen DC; Tan YL; Tan SP; Hui L; Lv MH; Soares JC; Zhang XY
Psychopharmacology (Berl); 2015 Jan; 232(1):223-32. PubMed ID: 24994553
[TBL] [Abstract][Full Text] [Related]
7. Plasma total antioxidant status and cognitive impairments in schizophrenia.
Zhang XY; Chen DC; Xiu MH; Tang W; Zhang F; Liu L; Chen Y; Liu J; Yao JK; Kosten TA; Kosten TR
Schizophr Res; 2012 Aug; 139(1-3):66-72. PubMed ID: 22555016
[TBL] [Abstract][Full Text] [Related]
8. Association between DBH 19bp insertion/deletion polymorphism and cognition in schizophrenia with and without tardive dyskinesia.
Hui L; Han M; Yin GZ; Zhang Y; Huang XF; Qian ZK; Gu WG; Gu XC; Zhu XM; Soares JC; Ning Y; Zheng Y; Du XD; Zhang XY
Schizophr Res; 2017 Apr; 182():104-109. PubMed ID: 27776953
[TBL] [Abstract][Full Text] [Related]
9. Sex difference in association between tardive dyskinesia and cognitive deficits in patients with chronic schizophrenia.
Zhang W; Wang D; Zhou H; Chen D; Xiu M; Cui L; Zhang X
Schizophr Res; 2023 May; 255():140-147. PubMed ID: 36989671
[TBL] [Abstract][Full Text] [Related]
10. Disrupted antioxidant enzyme activity and elevated lipid peroxidation products in schizophrenic patients with tardive dyskinesia.
Zhang XY; Tan YL; Zhou DF; Cao LY; Wu GY; Haile CN; Kosten TA; Kosten TR
J Clin Psychiatry; 2007 May; 68(5):754-60. PubMed ID: 17503985
[TBL] [Abstract][Full Text] [Related]
11. Blood superoxide dismutase level in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements.
Zhang XY; Zhou DF; Cao LY; Chen DC; Zhu FY; Wu GY
Schizophr Res; 2003 Aug; 62(3):245-50. PubMed ID: 12837521
[TBL] [Abstract][Full Text] [Related]
12. Altered interleukin-18 levels are associated with cognitive impairment in chronic schizophrenia.
Wu JQ; Chen DC; Tan YL; Tan SP; Xiu MH; Wang ZR; Yang FD; Soares JC; Zhang XY
J Psychiatr Res; 2016 May; 76():9-15. PubMed ID: 26866662
[TBL] [Abstract][Full Text] [Related]
13. Altered IL-2, IL-6 and IL-8 serum levels in schizophrenia patients with tardive dyskinesia.
An HM; Tan YL; Shi J; Wang ZR; Soars JC; Wu JQ; Yang FD; Huang XF; Zhang XY
Schizophr Res; 2015 Mar; 162(1-3):261-8. PubMed ID: 25600548
[TBL] [Abstract][Full Text] [Related]
14. Decreased serum brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia.
Yang YQ; Sun S; Yu YQ; Li WJ; Zhang X; Xiu MH; Chen DC; De Yang F; Liu H; Li C; Kosten TR; Zhang XY
Neurosci Lett; 2011 Sep; 502(1):37-40. PubMed ID: 21798311
[TBL] [Abstract][Full Text] [Related]
15. Tardive dyskinesia in Chinese patients with schizophrenia: Prevalence, clinical correlates and relationship with cognitive impairment.
Liang Q; Wang D; Zhou H; Chen D; Xiu M; Cui L; Zhang X
J Psychiatr Res; 2022 Jul; 151():181-187. PubMed ID: 35489178
[TBL] [Abstract][Full Text] [Related]
16. Thioredoxin, a novel oxidative stress marker and cognitive performance in chronic and medicated schizophrenia versus healthy controls.
Zhang XY; Chen DC; Xiu MH; Yang FD; Tan YL; He S; Kosten TA; Kosten TR
Schizophr Res; 2013 Feb; 143(2-3):301-6. PubMed ID: 23238053
[TBL] [Abstract][Full Text] [Related]
17. Reduced serum TNF alpha level in chronic schizophrenia patients with or without tardive dyskinesia.
Tian L; Tan Y; Chen D; Lv M; Tan S; Soares JC; Zhang XY
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():259-64. PubMed ID: 24995685
[TBL] [Abstract][Full Text] [Related]
18. Interrelationships Between BDNF, Superoxide Dismutase, and Cognitive Impairment in Drug-Naive First-Episode Patients With Schizophrenia.
Xiu MH; Li Z; Chen DC; Chen S; Curbo ME; Wu HE; Tong YS; Tan SP; Zhang XY
Schizophr Bull; 2020 Dec; 46(6):1498-1510. PubMed ID: 32390043
[TBL] [Abstract][Full Text] [Related]
19. Reduced status of plasma total antioxidant capacity in schizophrenia with tardive dyskinesia.
Chen DC; Xiu MH; Liu H; Zhang BS; Wang Y; Kosten TR; Zhang XY
J Psychiatr Res; 2010 Nov; 44(15):1111-2. PubMed ID: 20398909
[No Abstract] [Full Text] [Related]
20. Low superoxide dismutase activity in schizophrenic patients with tardive dyskinesia.
Yamada K; Kanba S; Anamizu S; Ohnishi K; Ashikari I; Yagi G; Asai M
Psychol Med; 1997 Sep; 27(5):1223-5. PubMed ID: 9300527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
